I’m personally baffled by the compliance of holders who are comfortable with the current price, which really started when the raise price was posed at 1.3c despite the heads being close to 2.5c not long be fore. Prior to that, Idan and the board demonstrated very little action to garner interest from the Australian investing community. In fact, this remains consistent today. The last time Idan visited Australia was November 2022 if I’m not mistaken? Foot soldiers just walking in Indian file accepting Idan and the boards version of events is equally dangerous in my view. A foreign operating company what with no independent CFO and no presence (or even a desire to build our profile in Australia) have all contributed to the current sentiment and optics.
Most hold as they believe the tech has great application, but Idan cannot seem to close a deal. Even the medical company was Sytze’s connections and not Idan. He simply doesn’t know how to get a deal done.
From a tech perspective and financial prudence it has been managed well, but credit cannot be offered for many other aspects of their approach.
Pressure makes diamonds. Maybe channel some of your energy into putting these guys under some pressure. You might be surprised what transpires as a result.
